Erich James Zellmer, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3760 N Charles Porter Ave, Oak Harbor, WA 98278 Phone: 813-395-1061 |
Tuongvi Nguyen, General Practice Medicare: Medicare Enrolled Practice Location: Naval Hospital Oak Hbr, 3475 North Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9501 |
Dr. Carol Lynn Budzik, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9782 |
Dr. Timothy James Algiers Jr., M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9852 |
News Archive
Some House Democrats opposed to abortion are threatening to thwart health care reform legislation if it does not clearly steer away from funding abortions. Congress Daily reports: "With Republicans likely to try to use the emotional issue to draw support and money for 2010 contests, Democrats tried to make the bill 'abortion neutral' - maintaining existing federal policy without further restricting abortion rights.
Vivid dreams involving drinking and drug use are common among individuals in recovery. A study from the Massachusetts General Hospital Recovery Research Institute, published in the January issue of the Journal of Substance Abuse Treatment after online release in October 2018, finds these relapse dreams are more common in those with more severe clinical histories of alcohol and other drug problems.
Aeras and the Oxford-Emergent Tuberculosis Consortium (OETC) announce today the start of a Phase IIb proof-of-concept efficacy trial of a new investigational tuberculosis (TB) vaccine that involves people living with the human immunodeficiency virus.
New research evaluating the necessity of air travel indicates that as many as half of flights may be considered to lack importance to the travellers themselves, according to a study published by the Journal of Air Transport Management.
A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.
› Verified 6 days ago